Hematology (all articles)
Reviews: CAR T-Cell Therapy Toxicities and Side Effects
5 Feb, 2018 | 16:13h | UTCCAR T-Cell Therapy – What do you need to know for the ED? – emDocs (free)
Related reviews: Toxicities of chimeric antigen receptor T cells: recognition and management – Blood (free) AND Toxicity and management in CAR T-cell therapy – Molecular Therapy Oncolytics (free) AND New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management – Critical Care (free)
Review: Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease
4 Feb, 2018 | 17:46h | UTCRational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease – Nutrients (free)
Guideline: Management of Patients on Antithrombotic Agents Undergoing Endoscopy
4 Feb, 2018 | 17:34h | UTC
Guideline: Management of Immune Thrombocytopenia
4 Feb, 2018 | 17:35h | UTCManagement of immune thrombocytopenia: Korean experts recommendation in 2017 – Blood Research (free)
Guideline: Role of Bone-Modifying Agents in Multiple Myeloma
4 Feb, 2018 | 17:02h | UTCCommentary: Role of Bone-Modifying Agents in Multiple Myeloma: ASCO Clinical Practice Guideline Update – The ASCO Post (free)
Review: Current Approaches to Epistaxis Treatment in Primary and Secondary Care
30 Jan, 2018 | 19:56h | UTC
Review: Vancomycin-resistant Enterococcus Infection in the Hematopoietic Stem Cell Transplant Recipient
25 Jan, 2018 | 20:48h | UTC
Review: Heparin-Induced Thrombocytopenia in the Patient Who Is Critically Ill
23 Jan, 2018 | 14:30h | UTCHeparin-Induced Thrombocytopenia in the Patient Who Is Critically Ill – Chest (free)
Source: Critical Care Reviews Newsletter
Review: Pathophysiology and Treatment of Beta-Thalassemia
23 Jan, 2018 | 14:22h | UTCPathophysiology and treatment of patients with beta-thalassemia – an update – F1000 Research (free)
Research: Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
21 Jan, 2018 | 14:26h | UTCLong-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Monoclonal Gammopathy of Undetermined Significance: Risk for Progression to Cancer, Other Disorders Examined – Physician’s First Watch (free) AND Patients with blood cancer precursor at risk of developing cancer even after 30 years – Mayo Clinic, via EurekAlert (free)
Guideline: Prophylaxis of Invasive Fungal Infections in Patients with Haematological Malignancies
16 Jan, 2018 | 19:05h | UTC
Review: Aging, Hematopoiesis, and the Myelodysplastic Syndromes
16 Jan, 2018 | 17:22h | UTCAging, hematopoiesis, and the myelodysplastic syndromes – Blood Advances (free)
Current Treatment Algorithms in Hematology
13 Jan, 2018 | 19:02h | UTCIntroducing ‘Current Treatment Algorithms’ – On Medicine Blog (free)
Treatment algorithm 1: Essential thrombocythemia treatment algorithm 2018 – Blood Cancer Journal (free)
Treatment algorithm 2: Polycythemia vera treatment algorithm 2018 – Blood Cancer Journal (free)
Guideline: Fertility Preservation for Medical Reasons in Girls and Women
10 Jan, 2018 | 00:11h | UTC
Review: Mature Lymphoid Malignancies
10 Jan, 2018 | 00:07h | UTCMature lymphoid malignancies: origin, stem cells, and chronicity – Blood Advances (free)
Research: Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
4 Jan, 2018 | 17:13h | UTCMyeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma – The New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Stem Cell Transplant for Severe Scleroderma Improves Survival, Quality of Life – NIH (free) AND Stem Cell Transplantation Offers Hope For Severe Scleroderma – MedicalResearch (free)
Meta-Analysis: Carfilzomib-Associated Cardiovascular Adverse Events
4 Jan, 2018 | 17:01h | UTCCarfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis – JAMA Oncology (link to abstract – $ for full-text)
Commentaries: Carfilzomib can lead to cardiovascular toxicity in multiple myeloma patients – eCancer News (free) AND Higher Rates of Cardiovascular Adverse Events in Patients with MM Treated With Carfilzomib – AJMC (free) AND Important CV Risk Seen With Carfilzomib in Multiple Myeloma – Medscape (free registration required)
Transfusing blood Close to its use-by date does not increase deaths in critically ill adults
3 Jan, 2018 | 14:23h | UTCTransfusing blood close to its use-by date does not increase deaths in critically ill adults – NIHR Signal (free)
Original article: Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults – New England Journal of Medicine (link to abstract – $ for full-text)
Research: Direct Factor X Inhibitor vs Low-Molecular-Weight Heparin for Cancer-Associated VTE
1 Jan, 2018 | 12:12h | UTCSee original article in the NEJM (free)
Portal Vein Thrombosis: A Primer for Emergency Medicine Physicians
1 Jan, 2018 | 12:01h | UTCPortal Vein Thrombosis: A Primer for Emergency Medicine Physicians – emDocs (free)
Paediatric Amendment to Adult BSH Guidelines for Aplastic Anaemia
31 Dec, 2017 | 15:42h | UTCPaediatric amendment to adult BSH Guidelines for aplastic anaemia – British Journal of Haematology (free)
Systematic Review: Bisphosphonates in Multiple Myeloma
29 Dec, 2017 | 19:36h | UTCBisphosphonates in Multiple Myeloma – Cochrane Library (free summary)
Original article: Bisphosphonates in multiple myeloma: an updated network meta-analysis – Cochrane Library (free)
Review: Management of Venous Thromboembolism
27 Dec, 2017 | 21:47h | UTCUpdate on the management of venous thromboembolism – Cleveland Clinic Journal of Medicine (free)
Research: Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With NOACs
27 Dec, 2017 | 21:08h | UTC“Composite rates of recurrence and major bleeding were 12.4% in patients who initiated NOACs within 2 days after acute stroke, 2.1% in those who initiated NOACs between 3 and 14 days, and 9.1% in patients who initiated NOACs >14 days after acute stroke. Future randomized studies to assess timing of initiation and choice of agent in patients with acute stroke and AF are warranted”.
Guideline for the Prevention of Venous Thromboembolic Disease in Colorectal Surgery
26 Dec, 2017 | 23:23h | UTC